Du, Yunhui <br/><br/>
β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.  [electronic resource] 

 -  PloS one  2012 
 - e52911 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0052911  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-1 Receptor Antagonists--pharmacology<br/>Adrenergic beta-Agonists--pharmacology<br/>Aged<br/>Animals<br/>Autoantibodies--blood<br/>Cardiomyopathy, Dilated--immunology<br/>Cell Proliferation--drug effects<br/>Cyclic AMP-Dependent Protein Kinases--metabolism<br/>Female<br/>Humans<br/>Imidazoles--pharmacology<br/>Interferon-gamma--metabolism<br/>Isoproterenol--pharmacology<br/>Isoquinolines--pharmacology<br/>Male<br/>Metoprolol--pharmacology<br/>Middle Aged<br/>Phosphorylation--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyridines--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Adrenergic, beta-1--immunology<br/>Signal Transduction--drug effects<br/>Sulfonamides--pharmacology<br/>T-Lymphocytes--drug effects<br/>p38 Mitogen-Activated Protein Kinases--metabolism